tricare glp-1 MOAA Tricare to end coverage of
Description
Consumers of GLP-1 medications such as Ozempic and Wegovy likely need dietary supplements for proper nutrition

Slower Digestion

The Trump Administration is dropping a Biden-era proposal that aimed to expand medicare and medicaid coverage to include costly weight-loss drugs.

Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.

The company is also under investigation by the FDA regarding its practices around compounded GLP-1 medications for weight management

These innovative medications are effective and increasingly accessible to everyone, including those with limited incomes